Sign inGet started

VYGR

Voyager Therapeutics, Inc.CIK 1640266 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40

AI insights for VYGR PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for VYGR
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Onyia JudeDirector5$0$02026-06-09
Vitale NancyDirector7$0$02026-06-09
Colon GraceDirector5$0$02026-06-09
Hyman StevenDirector11$0$02026-06-09
MACKEY CATHERINE JDirector5$0$02026-06-09
Higgins Michael JInterim President & CEO14$0$93.1K2026-06-09
PIERCE GLENNInterim CSO16$92.2K$63.7K2026-06-09
GERAGHTY JAMES ADirector13$113.1K$02026-06-09
SCANGOS GEORGE ADirector5$0$02026-06-09
Sandrock AlfredPresident and CEO21$0$620.4K2026-04-02
Shiferman Gregory L.SVP and General Counsel2$0$02026-04-01
Carter Todd AlfredChief Scientific Officer32$0$367.9K2026-02-24
Swartz RobinChief Operating Officer27$0$451.4K2026-02-24
Jorgensen Nathan D.Chief Financial Officer8$0$54.2K2026-02-24
Ferguson TobyChief Medical Officer8$0$105.5K2026-02-06
Fahey Sandell JacquelynChief Legal Officer8$0$54.3K2025-02-21
PFREUNDSCHUH PETER P.Chief Financial Officer8$0$122.9K2024-02-21
Hesslein Robert W.Senior VP & General Counsel22$0$258.6K2023-03-20
NEUROCRINE BIOSCIENCES INC10% Owner2$89.02M$02023-02-23
Third Rock Ventures III, L.P.10% Owner6$0$4.98M2023-02-02
TEPPER ROBERT I10% Owner1$0$451.0K2023-01-27
Third Rock Ventures GP III, L.P.10% Owner9$0$7.30M2023-01-23
EcoR1 Capital, LLC10% Owner5$2.66M$7.14M2023-01-11
Burek JulieVP, Finance11$0$35.5K2022-03-21
PAUL STEVEN MPresident and CEO7$140.7K$02021-06-03
LEVIN MARK JDirector, 10% Owner12$0$02021-06-03
Khwaja OmarSee remarks10$0$85.8K2021-05-21
Turenne AndrePresident & CEO11$0$293.3K2021-03-19
Dorval AllisonChief Financial Officer11$0$91.2K2021-03-19
DIXON WENDY LDirector5$0$02020-06-04
Ottmer Matthew P.Chief Operating Officer5$0$49.8K2020-01-21
KARSEN PERRY ADirector4$0$02019-06-13
Sah Dinah Ph.D.Chief Scientific Officer12$0$468.7K2019-01-11
TRV GP III, LLC10% Owner2$0$02018-09-19
Ravina BernardChief Medical Officer11$0$848.6K2018-04-10
Henderson JaneSr. V.P. & CFO, Corp. Dev.14$0$1.03M2018-03-23
Goater JeffChief Financial Officer2$0$02016-02-01
Hadley Harbor Master Investors (Cayman) L.P.10% Owner2$0$02015-11-16
STARR KEVIN P10% Owner2$0$02015-11-16
SanofiOther3$1.75M$02015-11-16

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
PIERCE GLENNDirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Colon GraceDirector A Award deriv2026-06-092026-06-1130,000— $00SEC↗
GERAGHTY JAMES ADirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Onyia JudeDirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Higgins Michael JDirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Vitale NancyDirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Hyman StevenDirector A Award deriv2026-06-092026-06-1130,000— $00SEC↗
MACKEY CATHERINE JDirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
SCANGOS GEORGE ADirector A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
Sandrock AlfredPresident and CEO S Sale2026-04-022026-04-0311,511$3.87 $44.5K472,549SEC↗
Shiferman Gregory L.SVP and General Counsel A Award2026-04-012026-04-0350,000— $050,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2026-02-242026-02-264,174$3.76 $15.7K145,718SEC↗
Jorgensen Nathan D.Chief Financial Officer S Sale2026-02-242026-02-264,668$3.77 $17.6K151,416SEC↗
Sandrock AlfredPresident and CEO S Sale2026-02-242026-02-2614,197$3.79 $53.8K484,060SEC↗
Swartz RobinCOO & CBO S Sale2026-02-242026-02-266,458$3.77 $24.3K199,738SEC↗
Sandrock AlfredPresident and CEO S Sale2026-02-182026-02-2011,732$3.41 $40.0K498,257SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2026-02-182026-02-203,301$3.44 $11.4K149,892SEC↗
Swartz RobinCOO & CBO S Sale2026-02-182026-02-203,882$3.44 $13.4K206,196SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2026-02-102026-02-113,525$3.85 $13.6K153,193SEC↗
Sandrock AlfredPresident and CEO S Sale2026-02-102026-02-1112,192$3.78 $46.1K509,989SEC↗
Swartz RobinCOO & CBO S Sale2026-02-102026-02-114,569$3.85 $17.6K210,078SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award deriv2026-02-062026-02-10150,500— $0150,500SEC↗
Sandrock AlfredPresident and CEO A Award deriv2026-02-062026-02-10402,500— $0402,500SEC↗
Swartz RobinCOO & CBO A Award deriv2026-02-062026-02-10210,000— $0210,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award deriv2026-02-062026-02-10154,000— $0154,000SEC↗
Ferguson TobyChief Medical Officer A Award deriv2026-02-062026-02-10210,000— $0210,000SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award2026-02-062026-02-1032,250— $0156,084SEC↗
Sandrock AlfredPresident and CEO A Award2026-02-062026-02-1086,250— $0522,181SEC↗
Swartz RobinCOO & CBO A Award2026-02-062026-02-1045,000— $0214,647SEC↗
Carter Todd AlfredChief Scientific Officer A Award2026-02-062026-02-1033,000— $0156,718SEC↗
Ferguson TobyChief Medical Officer A Award2026-02-062026-02-1045,000— $0183,914SEC↗
Shiferman Gregory L.SVP and General Counsel A Award deriv2026-01-062026-01-08100,000— $0100,000SEC↗
Jorgensen Nathan D.Chief Financial Officer S Sale2025-10-032025-10-077,666$4.78 $36.6K123,834SEC↗
Ferguson TobyChief Medical Officer S Sale2025-08-182025-08-2019,000$3.73 $70.9K138,914SEC↗
Colon GraceDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
Higgins Michael JDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
Hyman StevenDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
MACKEY CATHERINE JDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
Onyia JudeDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
PIERCE GLENNDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
SCANGOS GEORGE ADirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
Vitale NancyDirector A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
Sandrock AlfredPresident and CEO S Sale2025-04-022025-04-0410,885$3.43 $37.3K430,931SEC↗
Ferguson TobyChief Medical Officer S Sale2025-04-022025-04-0410,086$3.43 $34.6K157,914SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award deriv2025-02-212025-02-24103,000— $0103,000SEC↗
Ferguson TobyChief Medical Officer A Award deriv2025-02-212025-02-24126,000— $0126,000SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award deriv2025-02-212025-02-2483,000— $083,000SEC↗
Swartz RobinCOO & CBO A Award deriv2025-02-212025-02-24142,500— $0142,500SEC↗
Sandrock AlfredPresident and CEO A Award deriv2025-02-212025-02-24290,000— $0290,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award deriv2025-02-212025-02-2492,000— $092,000SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award2025-02-212025-02-2451,500— $0131,500SEC↗
Ferguson TobyChief Medical Officer A Award2025-02-212025-02-2463,000— $0168,000SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award2025-02-212025-02-2441,500— $0123,143SEC↗
Swartz RobinCOO & CBO A Award2025-02-212025-02-2471,250— $0169,647SEC↗
Sandrock AlfredPresident and CEO A Award2025-02-212025-02-24145,000— $0441,816SEC↗
Carter Todd AlfredChief Scientific Officer A Award2025-02-212025-02-2446,000— $0123,718SEC↗
Swartz RobinCOO & CBO S Sale2025-02-202025-02-243,894$4.25 $16.5K98,397SEC↗
Sandrock AlfredPresident and CEO S Sale2025-02-202025-02-2411,702$4.24 $49.6K296,816SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2025-02-202025-02-243,305$4.26 $14.1K77,718SEC↗
Fahey Sandell JacquelynChief Legal Officer S Sale2025-02-112025-02-124,358$4.45 $19.4K81,643SEC↗
Sandrock AlfredPresident & CEO S Sale2025-02-112025-02-1216,644$4.45 $74.1K308,518SEC↗
Swartz RobinCOO & CBO S Sale2025-02-112025-02-126,950$4.45 $30.9K102,291SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2025-02-112025-02-125,413$4.45 $24.1K81,023SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2025-01-142025-01-151,191$5.13 $6.1K86,436SEC↗
Swartz RobinCOO & CBO S Sale2025-01-142025-01-153,087$5.09 $15.7K109,241SEC↗
Swartz RobinCOO&CBO S Sale2024-12-232024-12-266,500$5.65 $36.7K112,328SEC↗
Fahey Sandell JacquelynChief Legal Officer S Sale2024-10-022024-10-035,999$5.82 $34.9K86,001SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award2024-10-012024-10-0280,000— $080,000SEC↗
Jorgensen Nathan D.Chief Financial Officer A Award deriv2024-07-082024-07-09200,000— $0200,000SEC↗
Colon GraceDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
Higgins Michael JDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
Hyman StevenDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
MACKEY CATHERINE JDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
Onyia JudeDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
PIERCE GLENNDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
SCANGOS GEORGE ADirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
Vitale NancyDirector A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
Sandrock AlfredPresident and CEO S Sale2024-04-022024-04-0312,115$9.86 $119.5K322,839SEC↗
Swartz RobinChief Operating Officer S Sale2024-04-022024-04-031,357$9.88 $13.4K117,004SEC↗
Ferguson TobyChief Medical Officer A Award2024-04-012024-04-03105,000— $0105,000SEC↗
Ferguson TobyChief Medical Officer A Award deriv2024-03-252024-03-26210,000— $0210,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2024-02-212024-02-223,365$7.47 $25.1K87,627SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer S Sale2024-02-212024-02-223,764$7.46 $28.1K175,669SEC↗
Sandrock AlfredPresident and CEO S Sale2024-02-212024-02-2213,033$7.46 $97.2K334,954SEC↗
Swartz RobinChief Operating Officer S Sale2024-02-212024-02-223,966$7.45 $29.5K118,361SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2024-02-202024-02-22602$7.68 $4.6K90,992SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award deriv2024-02-092024-02-1660,000— $060,000SEC↗
Sandrock AlfredPresident and CEO A Award deriv2024-02-092024-02-16260,000— $0260,000SEC↗
Swartz RobinChief Operating Officer A Award deriv2024-02-092024-02-16100,000— $0100,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award deriv2024-02-092024-02-1677,000— $077,000SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award deriv2024-02-092024-02-1662,000— $062,000SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award2024-02-092024-02-1630,000— $0179,433SEC↗
Sandrock AlfredPresident and CEO A Award2024-02-092024-02-16130,000— $0347,987SEC↗
Swartz RobinChief Operating Officer A Award2024-02-092024-02-1650,000— $0122,327SEC↗
Carter Todd AlfredChief Scientific Officer A Award2024-02-092024-02-1638,500— $091,594SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award2024-02-092024-02-1631,000— $092,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2024-01-172024-01-191,266$7.18 $9.1K53,094SEC↗
Swartz RobinChief Operating Officer S Sale2024-01-172024-01-192,543$7.15 $18.2K72,327SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer S Sale2023-10-032023-10-0513,567$6.99 $94.8K149,433SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award2023-10-012023-10-0261,000— $061,000SEC↗
Carter Todd AlfredChief Scientific Officer M Exercise deriv2023-09-152023-09-185,000— $040,000SEC↗
Carter Todd AlfredChief Scientific Officer M Exercise2023-09-152023-09-185,000$2.85 $14.3K64,860SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-09-152023-09-1810,500$8.16 $85.7K54,360SEC↗
Fahey Sandell JacquelynChief Legal Officer A Award deriv2023-07-102023-07-11122,000— $0122,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-07-062023-07-105,500$10.80 $59.4K59,860SEC↗
Carter Todd AlfredChief Scientific Officer M Exercise deriv2023-06-302023-07-055,000— $045,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-06-302023-07-055,000$11.41 $57.0K65,360SEC↗
Carter Todd AlfredChief Scientific Officer M Exercise2023-06-302023-07-055,000$2.85 $14.3K70,360SEC↗
Hyman StevenDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
SCANGOS GEORGE ADirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
Colon GraceDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
Higgins Michael JDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
Onyia JudeDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
Vitale NancyDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
MACKEY CATHERINE JDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
PIERCE GLENNDirector A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
SCANGOS GEORGE ADirector A Award deriv2023-05-092023-05-1144,000— $044,000SEC↗
Swartz RobinChief Operating Officer S Sale2023-04-032023-04-051,259$7.83 $9.9K71,617SEC↗
Sandrock AlfredPresident and CEO S Sale2023-04-032023-04-057,437$7.83 $58.2K214,618SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2023-03-202023-03-224,410$7.76 $34.2K102,200SEC↗
Swartz RobinChief Operating Officer S Sale2023-03-202023-03-223,654$7.76 $28.4K72,876SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-03-202023-03-222,193$7.76 $17.0K65,360SEC↗
Swartz RobinChief Operating Officer S Sale2023-03-152023-03-1715,373$8.20 $126.1K76,530SEC↗
Onyia JudeDirector A Award deriv2023-02-232023-02-2744,000— $044,000SEC↗
NEUROCRINE BIOSCIENCES INC10% Owner P Buy2023-02-232023-02-244,395,588$8.88 $39.03M8,575,316SEC↗
Sandrock AlfredPresident and CEO A Award deriv2023-02-172023-02-22240,000— $0240,000SEC↗
Swartz RobinChief Operating Officer A Award deriv2023-02-172023-02-2280,000— $080,000SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award deriv2023-02-172023-02-2276,000— $076,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award deriv2023-02-172023-02-2268,000— $068,000SEC↗
Sandrock AlfredPresident and CEO A Award2023-02-172023-02-22120,000— $0222,055SEC↗
Swartz RobinChief Operating Officer A Award2023-02-172023-02-2240,000— $091,903SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award2023-02-172023-02-2238,000— $0163,000SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-02-172023-02-22738$7.45 $5.5K67,553SEC↗
Carter Todd AlfredChief Scientific Officer A Award2023-02-172023-02-2234,000— $068,291SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2023-02-172023-02-223,297$7.45 $24.6K106,610SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2023-02-132023-02-152,868$7.67 $22.0K109,907SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-02-132023-02-15797$7.67 $6.1K34,291SEC↗
Third Rock Ventures III, L.P.10% Owner J Other2023-02-022023-02-061,500,000— $03,185,291SEC↗
Third Rock Ventures III, L.P.10% Owner S Sale2023-02-012023-02-01128,642$9.32 $1.20M4,685,291SEC↗
Third Rock Ventures III, L.P.10% Owner S Sale2023-01-312023-02-01185,000$9.25 $1.71M4,813,933SEC↗
Third Rock Ventures III, L.P.10% Owner S Sale2023-01-302023-02-0175,000$9.03 $677.3K4,998,933SEC↗
TEPPER ROBERT I10% Owner S Sale2023-01-272023-01-3150,000$9.02 $451.0K5,073,933SEC↗
Third Rock Ventures III, L.P.10% Owner S Sale2023-01-252023-01-2650,000$9.22 $461.0K5,123,933SEC↗
Third Rock Ventures III, L.P.10% Owner S Sale2023-01-242023-01-26100,000$9.27 $927.0K5,173,933SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2023-01-232023-01-2455,000$9.06 $498.3K5,273,933SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2023-01-202023-01-24100,000$9.15 $915.0K5,328,933SEC↗
Swartz RobinChief Operating Officer S Sale2023-01-172023-01-19792$10.34 $8.2K51,903SEC↗
Swartz RobinChief Operating Officer S Sale2023-01-172023-01-191,396$9.57 $13.4K52,695SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-01-172023-01-19400$10.34 $4.1K35,088SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-01-172023-01-19706$9.57 $6.8K35,488SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2023-01-172023-01-191,396$9.57 $13.4K113,567SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2023-01-172023-01-19792$10.34 $8.2K112,775SEC↗
EcoR1 Capital, LLC10% Owner S Sale2023-01-112023-01-11110,000$8.50 $935.0K3,851,507SEC↗
EcoR1 Capital, LLC10% Owner S Sale2023-01-102023-01-11336,400$8.05 $2.71M3,961,507SEC↗
EcoR1 Capital, LLC10% Owner S Sale2023-01-092023-01-11456,000$7.67 $3.50M4,297,907SEC↗
Carter Todd AlfredChief Scientific Officer S Sale2023-01-062023-01-10388$6.41 $2.5K36,194SEC↗
Colon GraceDirector A Award deriv2023-01-012023-01-0444,000— $044,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award2022-12-312023-01-10388$5.17 $2.0K36,582SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award2022-10-012022-10-04125,000— $0125,000SEC↗
PFREUNDSCHUH PETER P.Chief Financial Officer A Award deriv2022-09-192022-09-21200,000— $0200,000SEC↗
Carter Todd AlfredChief Scientific Officer A Award deriv2022-09-192022-09-21165,000— $0165,000SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2022-08-252022-08-26200,000$6.22 $1.24M5,428,933SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2022-08-242022-08-26149,972$6.09 $913.3K5,628,933SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2022-08-162022-08-18128,456$6.04 $775.9K5,778,905SEC↗
MACKEY CATHERINE JDirector A Award deriv2022-08-152022-08-1644,000— $044,000SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2022-08-152022-08-16135,808$6.04 $820.3K5,907,361SEC↗
Third Rock Ventures GP III, L.10% Owner S Sale2022-08-122022-08-16348,007$6.12 $2.13M6,043,169SEC↗
Higgins Michael JDirector S Sale2022-07-142022-07-1813,891$6.70 $93.1K31,314SEC↗
PIERCE GLENNDirector S Sale2022-07-142022-07-189,512$6.70 $63.7K16,788SEC↗
EcoR1 Capital, LLC10% Owner P Buy2022-06-232022-06-23376,000$5.66 $2.13M4,753,907SEC↗
EcoR1 Capital, LLC10% Owner P Buy2022-06-212022-06-23101,400$5.28 $535.4K4,377,907SEC↗
PIERCE GLENNDirector A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
Vitale NancyDirector A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
Higgins Michael JDirector A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
Hyman StevenDirector A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2022-04-042022-04-062,786$8.25 $23.0K114,963SEC↗
Swartz RobinChief Operating Officer S Sale2022-04-042022-04-061,527$8.25 $12.6K52,060SEC↗
Sandrock AlfredPresident and CEO A Award deriv2022-03-222022-03-23940,600— $0940,600SEC↗
Sandrock AlfredPresident and CEO A Award2022-03-222022-03-23100,000— $0100,000SEC↗
Burek JulieVP, Finance S Sale2022-03-212022-03-232,618$8.29 $21.7K52,489SEC↗
Burek JulieVP, Finance S Sale2022-03-212022-03-2331$8.68 $26952,458SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2022-03-212022-03-234,897$8.29 $40.6K117,807SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2022-03-212022-03-2358$8.68 $503117,749SEC↗
Swartz RobinChief Operating Officer S Sale2022-03-212022-03-234,362$8.29 $36.2K53,638SEC↗
Swartz RobinChief Operating Officer S Sale2022-03-212022-03-2351$8.68 $44353,587SEC↗
Burek JulieVP, Finance S Sale2022-02-172022-02-22789$3.55 $2.8K55,107SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2022-02-172022-02-224,100$3.55 $14.6K122,704SEC↗
Burek JulieVP, Finance S Sale2022-02-112022-02-15361$3.36 $1.2K55,896SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2022-02-112022-02-153,252$3.36 $10.9K126,804SEC↗
Sandrock AlfredDirector A Award deriv2022-02-072022-02-0944,000— $044,000SEC↗
Swartz RobinChief Operating Officer A Award deriv2022-02-072022-02-0965,000— $065,000SEC↗
Higgins Michael JInterim President & CEO A Award deriv2022-01-132022-01-18161,000— $0161,000SEC↗
PIERCE GLENNInterim CSO A Award deriv2022-01-132022-01-1850,000— $050,000SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award deriv2022-01-132022-01-18120,000— $0120,000SEC↗
Burek JulieVP, Finance A Award deriv2022-01-132022-01-1840,000— $040,000SEC↗
Higgins Michael JInterim President & CEO A Award2022-01-132022-01-1845,205— $045,205SEC↗
PIERCE GLENNInterim CSO A Award2022-01-132022-01-1826,300— $026,300SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award2022-01-132022-01-1820,000— $0130,056SEC↗
Burek JulieVP, Finance A Award2022-01-132022-01-1810,000— $056,257SEC↗
Burek JulieVP, Finance S Sale2022-01-122022-01-14265$3.06 $81146,257SEC↗
Burek JulieVP, Finance S Sale2022-01-032022-01-143,063$2.83 $8.7K46,522SEC↗
Burek JulieVP, Finance A Award2021-12-312022-01-143,063$2.30 $7.0K49,585SEC↗
Burek JulieVP, Finance A Award deriv2021-11-262021-11-3025,000— $025,000SEC↗
Burek JulieVP, Finance A Award2021-11-262021-11-3013,500— $046,522SEC↗
PIERCE GLENNInterim CSO A Award deriv2021-06-072021-06-0842,000— $042,000SEC↗
PIERCE GLENNInterim CSO A Award deriv2021-06-032021-06-0450,000— $050,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2021-06-032021-06-0415,000— $015,000SEC↗
LEVIN MARK JDirector, 10% Owner A Award deriv2021-06-032021-06-0415,000— $015,000SEC↗
Higgins Michael JInterim President & CEO A Award deriv2021-06-032021-06-04115,000— $0115,000SEC↗
Hyman StevenDirector A Award deriv2021-06-032021-06-0415,000— $015,000SEC↗
PAUL STEVEN MDirector A Award deriv2021-06-032021-06-0415,000— $015,000SEC↗
Vitale NancyDirector A Award deriv2021-06-032021-06-0415,000— $015,000SEC↗
Khwaja OmarSee remarks S Sale2021-05-212021-05-253,516$4.03 $14.2K120,509SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2021-04-052021-04-073,292$4.95 $16.3K110,056SEC↗
Dorval AllisonChief Financial Officer A Award2021-03-192021-03-2330,000— $0109,894SEC↗
Turenne AndrePresident & CEO A Award2021-03-192021-03-2380,000— $0322,375SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award2021-03-192021-03-2330,000— $0113,348SEC↗
Khwaja OmarSee Remarks A Award2021-03-192021-03-2335,000— $0124,025SEC↗
Dorval AllisonChief Financial Officer A Award deriv2021-02-162021-02-1868,000— $068,000SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award deriv2021-02-162021-02-1868,000— $068,000SEC↗
Khwaja OmarSee Remarks A Award deriv2021-02-162021-02-1872,000— $072,000SEC↗
Turenne AndrePresident & CEO A Award deriv2021-02-162021-02-18189,000— $0189,000SEC↗
Dorval AllisonChief Financial Officer A Award2021-02-162021-02-1834,000— $079,894SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award2021-02-162021-02-1834,000— $083,348SEC↗
Khwaja OmarSee Remarks A Award2021-02-162021-02-1836,000— $089,025SEC↗
Turenne AndrePresident & CEO A Award2021-02-162021-02-1894,000— $0242,375SEC↗
Khwaja OmarSee remarks S Sale2021-02-112021-02-163,475$7.55 $26.2K53,025SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2021-02-112021-02-163,186$7.55 $24.1K49,348SEC↗
Dorval AllisonChief Financial Officer S Sale2021-02-112021-02-163,186$7.55 $24.1K45,894SEC↗
Turenne AndrePresident & CEO S Sale2021-02-112021-02-167,977$7.55 $60.2K148,375SEC↗
Dorval AllisonChief Financial Officer S Sale2021-01-122021-01-142,942$8.62 $25.4K49,080SEC↗
Turenne AndrePresident & CEO S Sale2021-01-122021-01-1410,443$8.62 $90.0K156,352SEC↗
Vitale NancyDirector A Award deriv2020-09-152020-09-1630,000— $030,000SEC↗
LEVIN MARK JDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
PAUL STEVEN MDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
DIXON WENDY LDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
Hyman StevenDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
Higgins Michael JDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
PIERCE GLENNDirector A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
Khwaja OmarSee remarks S Sale2020-05-212020-05-223,500$12.96 $45.4K56,500SEC↗
Hesslein Robert W.Senior VP & General Counsel S Sale2020-04-032020-04-073,091$8.51 $26.3K52,534SEC↗
Turenne AndrePresident & CEO A Award deriv2020-02-102020-02-12162,500— $0162,500SEC↗
Khwaja OmarSee Remarks A Award deriv2020-02-102020-02-1260,000— $060,000SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award deriv2020-02-102020-02-1255,000— $055,000SEC↗
Dorval AllisonChief Financial Officer A Award deriv2020-02-102020-02-1255,000— $055,000SEC↗
Turenne AndrePresident & CEO A Award2020-02-102020-02-1281,250— $0166,795SEC↗
Khwaja OmarSee Remarks A Award2020-02-102020-02-1230,000— $060,000SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award2020-02-102020-02-1227,500— $055,625SEC↗
Dorval AllisonChief Financial Officer A Award2020-02-102020-02-1227,500— $052,022SEC↗
Turenne AndrePresident & CEO S Sale2020-01-212020-01-2910,705$13.36 $143.0K85,545SEC↗
Ottmer Matthew P.Chief Operating Officer S Sale2020-01-212020-01-293,724$13.36 $49.8K26,276SEC↗
Dorval AllisonChief Financial Officer S Sale2020-01-212020-01-293,128$13.36 $41.8K24,522SEC↗
DIXON WENDY LDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
Hyman StevenDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
Higgins Michael JDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
LEVIN MARK JDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
PIERCE GLENNDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
KARSEN PERRY ADirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
PAUL STEVEN MDirector A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
Khwaja OmarSee Remarks A Award deriv2019-05-202019-05-22170,000— $0170,000SEC↗
Khwaja OmarSee Remarks A Award2019-05-202019-05-2230,000— $030,000SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award deriv2019-04-012019-04-03168,750— $0168,750SEC↗
Hesslein Robert W.Senior VP & General Counsel A Award2019-04-012019-04-0328,125— $028,125SEC↗
NEUROCRINE BIOSCIENCES INC10% Owner P Buy2019-03-122019-03-144,179,728$11.96 $49.99M4,179,728SEC↗
Dorval AllisonChief Financial Officer A Award deriv2019-01-112019-01-1750,000— $050,000SEC↗
Ottmer Matthew P.Chief Operating Officer A Award deriv2019-01-112019-01-1760,000— $060,000SEC↗
Sah Dinah Ph.D.Chief Scientific Officer A Award deriv2019-01-112019-01-1750,000— $050,000SEC↗
Turenne AndrePresident & CEO A Award deriv2019-01-112019-01-17192,500— $0192,500SEC↗
Dorval AllisonChief Financial Officer A Award2019-01-112019-01-1725,000— $026,106SEC↗
Ottmer Matthew P.Chief Operating Officer A Award2019-01-112019-01-1730,000— $030,000SEC↗
Sah Dinah Ph.D.Chief Scientific Officer A Award2019-01-112019-01-1725,000— $0163,688SEC↗
Turenne AndrePresident & CEO A Award2019-01-112019-01-1796,250— $096,250SEC↗
Dorval AllisonChief Financial Officer A Award deriv2018-11-072018-11-0945,000— $045,000SEC↗
LEVIN MARK JDirector, 10% Owner J Other2018-09-192018-09-191,500,000— $06,391,176SEC↗
TRV GP III, LLC10% Owner J Other2018-09-192018-09-191,500,000— $06,391,176SEC↗
PIERCE GLENNDirector P Buy2018-09-122018-09-125,000$18.44 $92.2K5,000SEC↗
GERAGHTY JAMES ADirector P Buy2018-09-102018-09-123,000$19.39 $58.2K76,588SEC↗
GERAGHTY JAMES ADirector P Buy2018-08-172018-08-213,000$18.31 $54.9K73,588SEC↗
Turenne AndrePresident & CEO A Award deriv2018-07-162018-07-18650,000— $0650,000SEC↗
LEVIN MARK JDirector, 10% Owner J Other2018-06-202018-06-211,500,000— $07,891,176SEC↗
TRV GP III, LLC10% Owner J Other2018-06-202018-06-211,500,000— $07,891,176SEC↗
KARSEN PERRY ADirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
DIXON WENDY LDirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
Hyman StevenDirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
LEVIN MARK JDirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
Higgins Michael JDirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
PIERCE GLENNDirector A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
Ravina BernardChief Medical Officer S Sale2018-04-102018-04-122,451$18.38 $45.0K0SEC↗
Henderson JaneSr. V.P. & CFO, Corp. Dev. M Exercise deriv2018-03-232018-03-2611,200— $0165,584SEC↗
Henderson JaneSr. V.P. & CFO, Corp. Dev. M Exercise2018-03-232018-03-2611,200$11.97 $134.1K11,200SEC↗
Henderson JaneSr. V.P. & CFO, Corp. Dev. S Sale2018-03-232018-03-2611,200$20.52 $229.8K0SEC↗
Henderson JaneSr. V.P. & CFO, Corp. Dev. M Exercise deriv2018-03-222018-03-2619,900— $0176,784SEC↗
Henderson JaneSr. V.P. & CFO, Corp. Dev. S Sale2018-03-222018-03-2619,900$21.07 $419.3K0SEC↗